Thrombotic Sinusoiditis and Local Diffuse Intrasinusoidal Coagulation in the Liver of Subjects Affected by COVID-19: the Evidence from Histology and Scanning Electron Microscopy
Overview
Pharmacology
Toxicology
Authors
Affiliations
Objective: Liver injury has been reported in patients with COVID-19. This condition is characterized by severe outcome and could be related with the ability of SARS-CoV-2 to activate cytotoxic T cells. The purpose of this study is to show the histological and scanning electron microscopy features of liver involvement in COVID-19 to characterize the liver changes caused by the activation of multiple molecular pathways following this infection.
Patients And Methods: Liver biopsies from 4 patients (3 post-mortems and 1 in vivo) with COVID-19 were analyzed with histology and by scanning electron microscopy.
Results: The liver changes showed significant heterogeneity. The first case showed ground glass hepatocytes and scattered fibrin aggregates in the sinusoidal lumen. The second evidenced intra-sinusoidal thrombi. The third was characterized by sinusoidal dilatation, atrophy of hepatocytes, Disse's spaces dilatation and intra-sinusoidal aggregates of fibrin and red blood cells. The fourth case exhibited diffuse fibrin aggregates in the dilated Disse spaces and microthrombi in the sinusoidal lumen.
Conclusions: In COVID-19-related liver injury, a large spectrum of pathological changes was observed. The most peculiar features were very mild inflammation, intra-sinusoidal changes, including sinusoidal dilatation, thrombotic sinusoiditis and diffuse intra-sinusoidal fibrin deposition. These findings suggested that a thrombotic sinusoiditis followed by a local diffuse intra-vascular (intra-sinusoidal) coagulation could be the typical features of the SARS-CoV-2-related liver injury.
COVID-19 and the Liver: A Complex and Evolving Picture.
Taylor-Robinson S, Morgan M Hepat Med. 2023; 15:209-220.
PMID: 37965296 PMC: 10641025. DOI: 10.2147/HMER.S384172.
Liver Damage and Impaired Coagulation in COVID-19 Patients: A Case Series.
Abenavoli L, Aquila I, Sacco M, Scarlata G, Procopio A, Boccuto L Diseases. 2023; 11(4).
PMID: 37873785 PMC: 10594514. DOI: 10.3390/diseases11040141.
Cardiovascular disease/stroke risk stratification in deep learning framework: a review.
Bhagawati M, Paul S, Agarwal S, Protogeron A, Sfikakis P, Kitas G Cardiovasc Diagn Ther. 2023; 13(3):557-598.
PMID: 37405023 PMC: 10315429. DOI: 10.21037/cdt-22-438.
Fibrinogen, Fibrin, and Fibrin Degradation Products in COVID-19.
Kangro K, Wolberg A, Flick M Curr Drug Targets. 2022; 23(17):1593-1602.
PMID: 36029073 PMC: 10316333. DOI: 10.2174/1389450123666220826162900.
Torge D, Bernardi S, Arcangeli M, Bianchi S Pathogens. 2022; 11(8).
PMID: 36014988 PMC: 9415619. DOI: 10.3390/pathogens11080867.